Friday, July 18, 2025 7/18/2025

Platinum Based Countermeasures and Combinations with Protective Agents

Award Number: UG3NS134957
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/20/2024
PERIOD OF PERFORMANCE END DATE: 07/31/2026

Group Awards By:

View Award Description

Platinum Based Countermeasures and Combinations with Protective Agents - ABSTRACT This project's primary endpoint focus will be efficiently rescuing toxic cyanide exposure using three distinct animal models. None of the current countermeasure options meet the requirements for the risk scenarios and objectives in PAR 22-209. There are continual threats of chemical exposure to human populations. Health and safety measures in the workplace cannot fully mitigate the chances of unexpected or malicious use of chemical toxicants. Safe and effective countermeasures to a cyanide chemical exposures that can deploy in a variety of challenging emergency settings represent a continual unmet medical need. In addition to survival, mitigating the sequel morbidities of toxic chemical exposures means another challenge for next-generation countermeasures. For metabolic poisons that reach high levels of exposure like cyanide, approaches to reverse the insult's effects are warranted to mitigate more prolonged-term effects. A team of investigators with experience in discovering and developing countermeasures and therapeutic agents and expertise in medicinal chemistry, pharmacology, toxicology, discovery pharmaceutics, in vivo phenotypic screens, and complimentary animal models will pursue milestones established from 3 specific aims. Aim 1: To improve and down-select next-generation platinum (II)- based countermeasure agents hydrogen cyanide scavengers with properties that meet the criteria for developability. Aim 2: To evaluate combinations of the metabolite glyoxylate with platinum (II)-based scavenger agents. Aim 3: To evaluate the efficacy and safety in a porcine model for cyanide intoxication of lead candidate platinum (II)-based agents alone and in combinations with the metabolite glyoxylate.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $590,302 )
2024	2024	PURDUE UNIVERSITY	2550 NORTHWESTERN AVE # 1100	WEST LAFAYETTE	IN	47906	TIPPECANOE	USA	Cancer Treatment Research	000	1	8/19/2024	NEW	$590,302
														Subtotal = $590,302

Grand Total All Awards = $590,302

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Platinum Based Countermeasures and Combinations with Protective Agents

Award Number: UG3NS134957

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/20/2024

PERIOD OF PERFORMANCE END DATE: 07/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer